Health and Healthcare

Amgen : AMGN

All Amgen Articles

699 Articles

Douglas A. McIntyre | Jan 24, 2008 at 4:19 PM EST

Amgen’s Earnings & Guidance Make It Almost Look Like A Value Stock

Amgen Inc. (NASDAQ: AMGN) has announced earnings after the company released some positive data this morning. The troubled biotech giant…

Douglas A. McIntyre | Jan 24, 2008 at 7:04 AM EST

Amgen Tries Some Positive Data Ahead of Earnings (AMGN)

Amgen Inc. (NASDAQ: AMGN) has announced the results of its biomarker analysis in new data that will be presented on…

Douglas A. McIntyre | Jan 11, 2008 at 4:26 AM EST

Nasdaq Short Interest: Sellers Flee Big Tech

Based on the Nasdaq short interest in major stocks listed on the exchange as of December 31, shares short in…

Douglas A. McIntyre | Jan 4, 2008 at 3:22 PM EST

Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Today has been a rough day with more 52-week lows than we can recall in quite some time. The biotechs…

Douglas A. McIntyre | Dec 18, 2007 at 9:06 AM EST

Medarex Gets A Small Handout From Amgen (MEDX, AMGN)

Medarex, Inc. (NASDAQ: MEDX) has announced that it will receive a milestone payment from Amgen (NASDAQ: AMGN). Unfortunately, Medarex said…

Douglas A. McIntyre | Dec 14, 2007 at 4:25 AM EST

Media Digest 12/14/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Citigroup (C) will take $49 billion of SIVs onto its balance sheet. Reuters writes that Nissan and…

Douglas A. McIntyre | Dec 11, 2007 at 5:30 PM EST

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

We’ve had a lot of biotech stocks see their shares get the wrath of news over recent days. Now that…

Douglas A. McIntyre | Nov 15, 2007 at 7:57 AM EST

Top 10 Pre-Market Analyst Calls (AMGN, ENP, NTAP, PT, QCOM, SWIR, VCLK, VRSN, WY)

These aren’t all of the impact analyst calls, but these are the key calls that 24/7 Wall St. is focusing…

Douglas A. McIntyre | Oct 24, 2007 at 3:18 PM EDT

A Modest Quarter For Amgen (AMGN)

Wall St. expected Amgen (AMGN) to report a 1% decline in earnings to $1.03 a share on a 1% decline…

Douglas A. McIntyre | Oct 24, 2007 at 3:09 AM EDT

Media Digest 10/24/2007

According to Reuters, shares in Amazon (AMZN) dropped on concerns about margins in it latest earnings. Reuters writes that RIM…

Douglas A. McIntyre | Oct 17, 2007 at 5:08 AM EDT

The High Lay-Off Economy (BSX)(INTC)(CFC)(HPQ)

Workers in industries that are not doing well usually get laid off. But, it is not a good omen when…

Douglas A. McIntyre | Oct 17, 2007 at 3:08 AM EDT

Media Digest 10/17/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, the Mortgage Bankers Association said that mortgage originations will fall next year to the lowest levels since…

Douglas A. McIntyre | Oct 16, 2007 at 9:07 AM EDT

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Shares of Amgen Inc. (NASDAQ:AMGN) are under bit of pressure this morning, although not from any direct news from the…

Douglas A. McIntyre | Oct 13, 2007 at 7:55 AM EDT

Nasdaq Short Interest (LVLT)(MSFT)(SIRI)(INTC)

Below is the short interest for selected stocks traded on the Nasdaq. The figures are as of September 28 and…

Douglas A. McIntyre | Oct 12, 2007 at 4:01 AM EDT

Amgen: 24/7 & Business Week Compare & Contrast (AMGN, BIIB)

It seems that the thoughts of 24/7 Wall St. aren’t alone in the opinion of Amgen’s (NASDAQ:AMGN) future. In this…

1 … 43 44 45 46 47

Amgen : AMGN

All Amgen Articles

Amgen’s Earnings & Guidance Make It Almost Look Like A Value Stock

Amgen Tries Some Positive Data Ahead of Earnings (AMGN)

Nasdaq Short Interest: Sellers Flee Big Tech

Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Medarex Gets A Small Handout From Amgen (MEDX, AMGN)

Media Digest 12/14/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

Top 10 Pre-Market Analyst Calls (AMGN, ENP, NTAP, PT, QCOM, SWIR, VCLK, VRSN, WY)

A Modest Quarter For Amgen (AMGN)

Media Digest 10/24/2007

The High Lay-Off Economy (BSX)(INTC)(CFC)(HPQ)

Media Digest 10/17/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Nasdaq Short Interest (LVLT)(MSFT)(SIRI)(INTC)

Amgen: 24/7 & Business Week Compare & Contrast (AMGN, BIIB)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Amgen : AMGN

All Amgen Articles

Amgen’s Earnings & Guidance Make It Almost Look Like A Value Stock

Amgen Tries Some Positive Data Ahead of Earnings (AMGN)

Nasdaq Short Interest: Sellers Flee Big Tech

Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Medarex Gets A Small Handout From Amgen (MEDX, AMGN)

Media Digest 12/14/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

Top 10 Pre-Market Analyst Calls (AMGN, ENP, NTAP, PT, QCOM, SWIR, VCLK, VRSN, WY)

A Modest Quarter For Amgen (AMGN)

Media Digest 10/24/2007

The High Lay-Off Economy (BSX)(INTC)(CFC)(HPQ)

Media Digest 10/17/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Interpreting Amgen Sales From J&J’s PROCRIT (AMGN, JNJ)

Nasdaq Short Interest (LVLT)(MSFT)(SIRI)(INTC)

Amgen: 24/7 & Business Week Compare & Contrast (AMGN, BIIB)

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026